{"id":3475,"date":"2006-03-16T23:59:00","date_gmt":"2006-03-16T23:59:00","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=3475"},"modified":"2026-04-02T08:16:33","modified_gmt":"2026-04-02T08:16:33","slug":"vasella-isi-vede-visul-cu-ochii","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=3475","title":{"rendered":"Vasella isi vede visul cu ochii"},"content":{"rendered":"<p><P>Firma elvetiana Novartis a devenit cel mai mare producator de medicamente generice (fara prescriptie) din lume, dupa ce a preluat firma Hexal, al doilea furnizor de generice de pe piata germana, si 67,7% din actiunile companiei americane Eon Labs, intr-o tranzactie de 5,65 miliarde de euro. Novartis urmeaza sa integreze cele doua firme in divizia sa Sandoz, pana acum al doilea producator de generice din lume, dupa compania israeliana Teva Pharmaceuticals. Veniturile anuale ale Sandoz vor creste astfel la 5,1 mi-liarde de euro, fata de 4,8 mi-liarde pentru Teva. In plus, integrarea celor doua companii va avea ca rezultat reduceri de costuri de 200 de milioane de dolari in urmatorii trei ani.&nbsp; Achizitia de saptamana trecuta realizeaza astfel aspiratia mai veche a sefului Novartis, Daniel Vasella (foto), de a obtine prima pozitie pe piata mondiala a medicamentelor generice, adaugandu-se recentelor preluari ale firmelor Lek din Slovenia si Sabex din Canada.<BR><\/P><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Firma elvetiana Novartis a devenit cel mai mare producator de medicamente generice (fara prescriptie) din lume, dupa ce a preluat firma Hexal, al doilea furnizor de generice de pe piata germana, si 67,7% din actiunile companiei americane Eon Labs, intr-o tranzactie de 5,65 miliarde de euro. <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[632],"class_list":["post-3475","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-actualitate"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/3475","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3475"}],"version-history":[{"count":1,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/3475\/revisions"}],"predecessor-version":[{"id":24913,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/3475\/revisions\/24913"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3475"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3475"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3475"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}